STM
Journals
—
Open Access
Special Issue
Topic

Pharmacogenomics Used in the Intensive Care Unit

Guest Editor:

        • Abstract Submission Deadline : 30/11/2023

        Manuscript Submission Deadline : 25/12/2023

        [This article belongs to Special Issue Pharmacogenomics Used in the Intensive Care Unit under section rrjomst, rrjomst in (rrjomst, rrjomst)]

        Special Issue Description

        Pharmacogenomics is progressively getting to be a profitable instrument for progressing well-being results, decreasing wellbeing care costs, and dodging antagonistic medicate responses. Whereas the application of pharmacogenomics is very common in oncology and cardiology, schedule utilization of this innovation is uncommon in certain other areas counting Injury and Basic Care Surgery. Within the intensive care unit (ICU) setting, where profoundly variable and deficiently medicated efficacies, as well as the visit and unusual adverse drug reactions (ADRs), happen, pharmacogenomics (PGx) offers an opportunity to progress well-being results. The challenge of pharmacotherapy within the ICU is that patients may concurrently get the restorative treatment of numerous sedative-analgesics, antimicrobials, antifungal drugs, anticoagulants, and in some cases paralytics as well as solutions to restrain gastric corrosive emission. Basic ailment combined with preexisting constant infections regularly comes about in hepatic or renal inadequacy and, as a result, modifications in understanding the body’s deposition and reaction to drugs. Hence, the choice of the right pharmaceutical at the correct measurements is challenging, but basic, to maintain a strategic distance from serious and startling toxicities and to guarantee restorative adequacy.

        Editor Keywords

        Pharmacogenomics, Adverse drug reactions (ADRs), Intensive care unit (ICU), Sedative-analgesics, Antimicrobials, Antifungal drugs, Anticoagulants

        Manuscript Submission information

        Manuscripts should be submitted online by registering and logging in to this link. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed.
        Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent on email address:[email protected] for announcement on this website.

        Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

        Participating journals:

        Journal Name

        Research & Reviews : Journal of Medical Science and Technology, Research & Reviews : Journal of Medical Science and Technology

        Abbrivation

        rrjomst, rrjomst

        ISSN

        2319-3417, 2319-3417

        Since

        2012

        APC

        1000  $